Cargando...
Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment
At least 2.3 million people in the U.S. have an opioid use disorder, less than 40% of whom receive evidence-based treatment. Buprenorphine used as part of medication-assisted treatment has high potential to address this gap because of its approval for use in non-specialty outpatient settings, effect...
Guardado en:
| Publicado en: | Am J Prev Med |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6330240/ https://ncbi.nlm.nih.gov/pubmed/29779547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amepre.2017.12.022 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|